Nakai, Yuta
Okamoto, Kazuo
Terashima, Asuka
Ehata, Shogo
Nishida, Jun
Imamura, Takeshi
Ono, Takashi
Takayanagi, Hiroshi
Article History
Received: 27 March 2018
Revised: 31 July 2018
Accepted: 24 August 2018
First Online: 3 January 2019
Competing interests
: K.Okamoto and A.Terashima declare that they belong to an endowment department, Department of Osteoimmunology, supported with an unrestricted grant from Chugai Pharmaceutical Co., Ltd., AYUMI Pharmaceutical Corporation and Noevir Co., Ltd. The remaining authors declare no conflict of interest.